Vignati F, Berselli M E, Loi P
Divisione di Endocrinologia, Ospedale Niguarda Ca' Granda, Milano, Italia.
Eur J Endocrinol. 1994 Mar;130(3):235-41. doi: 10.1530/eje.0.1300235.
In the attempt to identify parameters that might predict the risk of recurrence of Cushing's disease at an early stage after successful pituitary microsurgery, we evaluated retrospectively the usefulness of an early postoperative determination of morning plasma and urinary cortisol levels and of adrenocorticotropin (ACTH) and cortisol responses to ovine corticotropin-releasing hormone (oCRH) stimulation in 30 patients with pituitary-driven Cushing's disease followed up for 9 months to 10 years after pituitary surgery. At an early postoperative evaluation, while off substitutive therapy, 30 patients, out of 36 treated by pituitary microsurgery for Cushing's disease, were considered in remission on the basis of subnormal (21 patients), low-normal (eight patients) or normal (one patient) morning plasma and urinary cortisol levels, whereas six patients with supranormal urinary cortisol excretion were considered as surgical failures. The plasma ACTH response to oCRH was subnormal (17 patients) or normal (four patients) in 21 patients (Group 1) and supranormal in nine patients (Group 2). All of the six patients with persistence of Cushing's disease had supranormal ACTH response to oCRH. Basal and oCRH-stimulated cortisol levels were subnormal in 25 out of 30 patients considered in remission. During long-term evaluation, six patients had recurrence of Cushing's disease 9 months to 5 years after surgery; their early postoperative mean basal morning plasma and mean urinary cortisol were higher than those recorded in patients who did not relapse, although a wide overlap between subjects was evident. In five out of these six patients urinary cortisol excretion had decreased to almost undetectable values during low-dose dexamethasone.(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定哪些参数可能在垂体显微手术成功后的早期阶段预测库欣病复发风险,我们回顾性评估了术后早期测定早晨血浆和尿皮质醇水平以及促肾上腺皮质激素(ACTH)和皮质醇对羊促肾上腺皮质激素释放激素(oCRH)刺激反应的实用性,对30例垂体性库欣病患者在垂体手术后进行了9个月至10年的随访。在术后早期评估时,在未进行替代治疗的情况下,36例接受垂体显微手术治疗库欣病的患者中,30例根据早晨血浆和尿皮质醇水平低于正常(21例)、低正常(8例)或正常(1例)被认为处于缓解期,而6例尿皮质醇排泄超常的患者被视为手术失败。21例患者(第1组)对oCRH的血浆ACTH反应低于正常(17例)或正常(4例),9例患者(第2组)反应超常。所有6例库欣病持续存在的患者对oCRH的ACTH反应均超常。在被认为缓解的30例患者中,25例的基础和oCRH刺激后的皮质醇水平低于正常。在长期评估中,6例患者在术后9个月至5年出现库欣病复发;他们术后早期的平均基础早晨血浆和平均尿皮质醇高于未复发患者记录的值,尽管两组之间有明显的重叠。在这6例患者中的5例,低剂量地塞米松治疗期间尿皮质醇排泄已降至几乎检测不到的值。(摘要截短于250字)